Posted on 10/26/18
Merck & Co Inc (MRK) Q3 2018 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOLMerck & Co Inc (NYSE:MRK)Q3 2018 Earnings Conference CallOct. 25, 2018, 8:00 a.m. ETContents: Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning, my . . .
Posted on 10/26/18
Celgene Corp (CELG) Q3 2018 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Celgene Corp (NASDAQ:CELG)Q3 2018 Earnings Conference CallOct. 25, 2018, 9:00 a.m. ETContents: Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning and welcome to . . .
Posted on 10/26/18
Incyte Named a 2018 Top Employer by Science Magazine
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today that it has been named one of the global biotechnology and pharmaceutical industry’s top employers by Science magazine, ranking . . .
Posted on 10/26/18
NeuroFlow Awarded Federal Grant to Conduct Research Study at Veterans’ Hospital
NeuroFlow, a mental health technology company, has been awarded a $225,000 Phase I Small Business Technology Transfer (STTR) grant from the National Science Foundation to accelerate . . .
Posted on 10/25/18
Merck Announces Third-Quarter 2018 Financial Results
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2018. “We built . . .
Posted on 10/25/18
Merck Announces Increased Fourth-Quarter Dividend and $10 Billion Share Repurchase Authorization
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that its Board of Directors has approved a 15 percent increase . . .
Posted on 10/25/18
Celgene Reports Third Quarter 2018 Operating and Financial Results
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) reported net product sales of $3,890 million for the third quarter of 2018, an 18 percent increase from the same period . . .
Posted on 10/25/18
Don't Sell Johnson & Johnson
Summary A recent article says JNJ should be sold because the talc lawsuits represent too big a danger at the current price. The threat to J&J . . .
Posted on 10/24/18
American Family Care Opening New Urgent Care in Cedar Grove, NJ
American Family Care, the nation's leading provider of urgent care and occupational medicine, continues to expand its national care network with the opening of the latest . . .
Posted on 10/24/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on October 17, 2018 it approved non-statutory stock options to purchase an aggregate of 68,700 shares of its . . .
Posted on 10/23/18
Blue Cross And Blue Shield Of Nebraska Selects Prudential Retirement To Oversee $138M Retirement Plan
NEWARK, N.J.--(BUSINESS WIRE)--Blue Cross and Blue Shield of Nebraska, an independent licensee of the Blue Cross and Blue Shield Association, hired Prudential Retirement to serve as . . .
Posted on 10/23/18
Quest Diagnostics Reports Third Quarter 2018 Financial Results
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2018 and . . .
Posted on 10/23/18
J&J Makes $2.1B Offer To Buy Out Ci:z
Johnson & Johnson (NYSE: JNJ) today announced that they have agreed with Ci:z Holdings Co., Ltd. (TYO: 4924), a Japanese company focused on the marketing, development . . .
Posted on 10/23/18
Why Celldex Therapeutics, Inc. Fell on Monday
What happenedShares of Celldex Therapeutics, Inc. (NASDAQ:CLDX), a clinical-stage biotech developing novel cancer therapies, fell 21.4% during midday trading on Monday despite a complete lack of . . .
Posted on 10/23/18
Osmotica Pharmaceuticals Closes IPO
BRIDGEWATER, N.J., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, today announced the closing of its initial public offering of . . .
Posted on 10/23/18
Aclaris Closes Public Offering of Common Stock
WAYNE, Pa., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to . . .
Posted on 10/22/18
Tabula Rasa HealthCare Announces the Launch of CareVention HealthCare
MOORESTOWN, N.J., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today . . .
Posted on 10/22/18
Quest Diagnostics Acquires Hurley Medical Center's Outreach Laboratory Services Operation in Central Michigan
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced it has acquired certain assets
Posted on 10/22/18
Topcon Healthcare Solutions Announces Clearance of Topcon Harmony
OAKLAND, N.J.--(BUSINESS WIRE)--Topcon Healthcare Solutions announces the release and clearance of Topcon Harmony, a class II medical diagnostic software. Topcon Harmony is a replacement of Synergy . . .
Posted on 10/22/18
Why Merck's Latest Success Means Trouble for Exelixis Inc.
Exelixis Inc. (NASDAQ:EXEL) was one of the best-performing biotech stocks of 2016, and it more than doubled in 2017 due to strong uptake of its kidney . . .
Posted on 10/22/18
What's Behind Johnson & Johnson's Q3 Earnings Success
Johnson & Johnson (NYSE:JNJ) is a healthcare Goliath that generates billions of dollars in revenue from consumer goods, pharmaceuticals, and medical devices. In the third quarter, . . .
Posted on 10/19/18
5 Things You Should Know About Johnson & Johnson's Third Quarter
Johnson & Johnson's (NYSE:JNJ) $20.3 billion in revenue in the third quarter was $300 million higher than anticipated, and its $2.05 in adjusted earnings per share . . .
Posted on 10/19/18
Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology
RUTHERFORD, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers . . .
Posted on 10/19/18
PhaseBio Prices IPO
MALVERN, Pa. and SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel . . .
Posted on 10/19/18
Osmotica Pharmaceuticals Prices IPO
BRIDGEWATER, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, today announced the pricing of its initial public offering of . . .

